Can BlissBio’s HER2-Targeting ADC Challenge Enhertu In Breast Cancer?

Eisai Deal Sets Stage For Battle

 
• By Dexter Jie Yan
challenger facing hurdles
Any serious challenger to Enhertu will face hurdles, especially in breast cancer • Source: Shutterstock

More from China

More from Focus On Asia